These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

120 related articles for article (PubMed ID: 6320489)

  • 1. Some properties of the human platelet vasopressin receptor.
    Thomas ME; Osmani AH; Scrutton MC
    Thromb Res; 1983 Dec; 32(6):557-66. PubMed ID: 6320489
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Mechanism of action and structural requirements of vasopressin analog inhibition of transepithelial water flux in toad urinary bladder.
    Mann WA; Stassen F; Huffman W; Kinter LB
    J Pharmacol Exp Ther; 1986 Aug; 238(2):401-6. PubMed ID: 3090234
    [TBL] [Abstract][Full Text] [Related]  

  • 3. V2-like vasopressin receptor mobilizes intracellular Ca2+ in rat medullary collecting tubules.
    Champigneulle A; Siga E; Vassent G; Imbert-Teboul M
    Am J Physiol; 1993 Jul; 265(1 Pt 2):F35-45. PubMed ID: 8342613
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Vasopressin inhibits the adenylate cyclase activity of human platelet particulate fraction through V1-receptors.
    Vanderwel M; Lum DS; Haslam RJ
    FEBS Lett; 1983 Dec; 164(2):340-4. PubMed ID: 6317457
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Vascular vasopressin receptors mediate inhibition of beta adrenergic receptor-induced cyclic AMP accumulation.
    Nambi P; Whitman M; Stassen FL; Crooke ST
    J Pharmacol Exp Ther; 1986 Apr; 237(1):143-6. PubMed ID: 3007735
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Characterization of vasopressin receptors in cultured cells derived from the region of rat brain circumventricular organs.
    Jurzak M; Müller AR; Gerstberger R
    Neuroscience; 1995 Apr; 65(4):1145-59. PubMed ID: 7617168
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Similarities between hamster pancreatic islet beta (HIT) cell vasopressin receptors and V1b receptors.
    Richardson SB; Laya T; VanOoy M
    J Endocrinol; 1995 Oct; 147(1):59-65. PubMed ID: 7490538
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Effect of 1-desamino-8-D-arginine vasopressin (DDAVP) on human platelets.
    Yang X; Disa J; Rao AK
    Thromb Res; 1990 Sep; 59(5):809-18. PubMed ID: 2237837
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Desensitization of renal vasopressin-stimulated adenylate cyclase by a vasopressor and antidiuretic antagonist, [1-(beta-mercapto-beta,beta-cyclopentamethylenepropionic acid),2-(O-ethyl)-D-tyrosine, 4-valine]arginine vasopressin.
    Chang P; Kimura K
    Biochem Biophys Res Commun; 1987 Apr; 144(2):770-8. PubMed ID: 3579941
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Relaxation of human isolated mesenteric arteries by vasopressin and desmopressin.
    Martínez MC; Vila JM; Aldasoro M; Medina P; Flor B; Lluch S
    Br J Pharmacol; 1994 Oct; 113(2):419-24. PubMed ID: 7834191
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Oxytocin causes endothelium-dependent relaxations of canine basilar arteries by activating V1-vasopressinergic receptors.
    Katusic ZS; Shepherd JT; Vanhoutte PM
    J Pharmacol Exp Ther; 1986 Jan; 236(1):166-70. PubMed ID: 3001282
    [TBL] [Abstract][Full Text] [Related]  

  • 12. 1-desamino-8-D-arginine vasopressin (DDAVP) as an agonist on V1b vasopressin receptor.
    Saito M; Tahara A; Sugimoto T
    Biochem Pharmacol; 1997 Jun; 53(11):1711-7. PubMed ID: 9264324
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Pharmacological characterization of vasopressin aggregation response of human platelets.
    DiTullio NW; Kinter LB; Storer BL
    Thromb Res; 1985 Nov; 40(3):425-32. PubMed ID: 4082118
    [No Abstract]   [Full Text] [Related]  

  • 14. C-terminal deletions in agonistic and antagonistic analogues of vasopressin that improve their specificities for antidiuretic (V2) and vasopressor (V1) receptors.
    Manning M; Misicka A; Olma A; Klis WA; Bankowski K; Nawrocka E; Kruszynski M; Kolodziejczyk A; Cheng LL; Seto J
    J Med Chem; 1987 Dec; 30(12):2245-52. PubMed ID: 2960812
    [TBL] [Abstract][Full Text] [Related]  

  • 15. The vasopressin-induced excitation of hypoglossal and facial motoneurons in young rats is mediated by V1a but not V1b receptors, and is independent of intracellular calcium signalling.
    Reymond-Marron I; Tribollet E; Raggenbass M
    Eur J Neurosci; 2006 Sep; 24(6):1565-74. PubMed ID: 17004920
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Neurohypophyseal peptides and tachykinins stimulate the production of cyclic GMP in cultured porcine aortic endothelial cells.
    Schini VB; Katusic ZS; Vanhoutte PM
    J Pharmacol Exp Ther; 1990 Dec; 255(3):994-1000. PubMed ID: 2175809
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Characteristics of the receptors which mediate the stimulation of ACTH secretion by vasopressin in conscious dogs.
    Schwartz J; Reid IA
    Neuroendocrinology; 1986; 42(2):93-6. PubMed ID: 3005898
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Proconvulsive effect of vasopressin; mediation by a putative V2 receptor subtype in the central nervous system.
    Croiset G; De Wied D
    Brain Res; 1997 Jun; 759(1):18-23. PubMed ID: 9219858
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [Effects of neurohypophysial hormones and their synthetic analogs on platelet aggregation].
    Golubeva MG; Grigor'eva ME
    Izv Akad Nauk Ser Biol; 2000; (5):631-5. PubMed ID: 11042970
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Synthesis and some pharmacological properties of potent and selective antagonists of the vasopressor (V1-receptor) response to arginine-vasopressin.
    Manning M; Stoev S; Bankowski K; Misicka A; Lammek B; Wo NC; Sawyer WH
    J Med Chem; 1992 Jan; 35(2):382-8. PubMed ID: 1531076
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.